Welcome to our dedicated page for Maximus SEC filings (Ticker: MMS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Maximus, Inc. (NYSE: MMS) SEC filings page on Stock Titan provides access to the company’s official disclosures as filed with the U.S. Securities and Exchange Commission. Maximus is a government services and technology company that reports its results and material events through periodic and current reports, including annual reports on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K. These documents cover topics such as segment performance across U.S. Federal Services, U.S. Services, and Outside the U.S., contract activity, capital allocation decisions, and risk disclosures.
Investors can use this page to review Maximus filings that discuss revenue drivers like clinical programs and tech-enabled service delivery, as well as information on operating margins, adjusted EBITDA, and free cash flow as described in the company’s non-GAAP reconciliations. Current reports on Form 8-K include items such as earnings releases, updates to stock purchase programs authorized by the Board of Directors, and certain leadership changes. For example, recent 8-K filings have covered financial results for specific periods, an increase to the stock purchase program authorization, and the planned resignation of a senior legal officer.
Stock Titan enhances these filings with AI-powered summaries that explain key points in clear language, helping readers understand complex sections of lengthy 10-K and 10-Q reports. Real-time updates from the SEC’s EDGAR system ensure that new Maximus filings, including Forms 3, 4, and 5 related to insider transactions, appear promptly on this page. Users can quickly identify when executives or directors report trades in MMS stock through Form 4 filings.
Whether you are looking for the latest annual report, quarterly results, details on capital deployment such as dividends and stock purchase programs, or specific 8-K disclosures about material events, this page offers a structured view of Maximus’ regulatory history, supported by AI summaries that highlight the most important information for analysis.
John T. Martinez, Chief Legal Officer of MAXIMUS, Inc. (MMS), reported a transaction dated 08/31/2025 on Form 4 showing the acquisition of 144.404 shares of common stock through dividend equivalent rights that accrued on previously awarded restricted stock units (RSUs) and certain performance share units (PSUs). The dividend equivalents vest proportionately with the underlying RSUs/PSUs and each right is economically equivalent to one share. The report lists 33,642.02 shares of common stock beneficially owned following the transaction and indicates the acquisition price as $0, reflecting in-kind dividend equivalence rather than a market purchase.
David Mutryn, Chief Financial Officer of MAXIMUS, Inc. (MMS), reported that on 08/31/2025 he acquired 178.911 dividend equivalent rights that are the economic equivalent of common stock and accrue with previously awarded restricted stock units (RSUs) and certain performance share units (PSUs) whose performance criteria have been met. The reported transaction shows 52,611.789 shares of common stock beneficially owned following the transaction. The filing was signed by an attorney-in-fact on 09/03/2025.
MAXIMUS, Inc. (MMS) insider report for Rajan Gayathri: The company filed a Form 4 showing the director acquired additional common stock through dividend reinvestment and accrued dividend-equivalent rights tied to previously awarded restricted stock units. On 08/29/2025, 41.452 shares were purchased at $87.576 via dividend reinvestment, bringing total beneficial ownership to 14,338.124 shares. On 08/31/2025, 7.493 shares were recorded as dividend equivalent rights with a $0 price, bringing total to 14,345.617 shares. The Form 4 was signed by an attorney-in-fact on behalf of Rajan Gayathri.
Raymond B. Ruddy, a director of MAXIMUS, Inc. (MMS), reported an acquisition on 08/31/2025 of 684.507 dividend equivalent rights tied to previously awarded restricted stock units (RSUs). These dividend equivalent rights are the economic equivalent of one share of MAXIMUS common stock and vest proportionately with the underlying RSUs. After the reported transaction, Mr. Ruddy beneficially owned 315,245.917 shares (or share equivalents). The Form 4 was signed on behalf of Mr. Ruddy by an attorney-in-fact on 09/03/2025.
Michael J. Warren, a director of MAXIMUS, Inc. (MMS), reported two non-derivative increases in his direct holdings executed through dividend-related mechanisms. On 08/29/2025 he acquired 14.114 shares via dividend reinvestment at a reported price of $87.575, bringing his direct beneficial ownership to 15,432.321 shares. On 08/31/2025 he received 38.551 shares as dividend equivalent rights tied to previously awarded restricted stock units, increasing his direct holdings to 15,470.872 shares. The Form 4 was signed by an attorney-in-fact on 09/03/2025.